Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-057696

Director sold 21,374 shares at $36.38 ($777,586)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Gallagher Carol Giltner Director 2018-11-07 Sale −21,374 $36.38 $777,586 88,818 D: show line 1 in the form
Open-market sales · 21,374 sh · avg $36.38 · $777,586
Loading xslF345X03/doc4.xml…